These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6373315)

  • 21. [Reduction of hypoglycemia in 10 diabetic patients treated with continuous subcutaneous infusion of insulin].
    Leblanc H; Obadia G; Passa P
    Presse Med; 1986 Mar; 15(10):463-6. PubMed ID: 2938089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microalbuminuria and nerve conduction velocity in type-I diabetics during conventional therapy and during continuous i.v. insulin infusion.
    Morell B; Meyer M; Porr O; Bay U; Froesch ER
    Acta Diabetol Lat; 1984; 21(4):303-13. PubMed ID: 6397022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients.
    Ziegler D; Wiefels K; Dannehl K; Gries FA
    Klin Wochenschr; 1988 May; 66(9):388-96. PubMed ID: 2839729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Ganes T; Kierulf P; Smeland E; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1986 Nov; 293(6556):1195-9. PubMed ID: 3096429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered recognition of hypoglycaemic symptoms in type I diabetes during intensified control with continuous subcutaneous insulin infusion.
    Lager I; Attvall S; Blohmé G; Smith U
    Diabet Med; 1986; 3(4):322-5. PubMed ID: 2949919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps.
    Pietri A; Ehle AL; Raskin P
    Diabetes; 1980 Aug; 29(8):668-71. PubMed ID: 7002680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased nerve conduction in diabetics after a year of improved glucoregulation.
    Ehle AL; Raskin P
    J Neurol Sci; 1986 Jul; 74(2-3):191-7. PubMed ID: 3525757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy.
    Boulton AJ; Drury J; Clarke B; Ward JD
    Diabetes Care; 1982; 5(4):386-90. PubMed ID: 7151654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous subcutaneous insulin infusion (CSII): therapeutic options.
    Ward JD
    Diabet Med; 1984 May; 1(1):47-50. PubMed ID: 6242777
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics.
    Gambardella S; Napoli A; Spallone V; Verrastro AM; Lazzari R; Geraldini C; Sideri G; Menzinger G
    J Endocrinol Invest; 1983 Oct; 6(5):363-7. PubMed ID: 6663037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients.
    Ziegler D; Dannehl K; Wiefels K; Gries FA
    Diabet Med; 1992; 9(7):622-9. PubMed ID: 1511568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy.
    Haug PJ; Kelly TM; Cannon RB; Edwards CQ
    J Neurol Sci; 1987 Dec; 82(1-3):123-32. PubMed ID: 3440863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes.
    Jakobsen J; Christiansen JS; Kristoffersen I; Christensen CK; Hermansen K; Schmitz A; Mogensen CE
    Diabetes; 1988 Apr; 37(4):452-5. PubMed ID: 3288533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction.
    Krönert K; Hülser J; Luft D; Stetter T; Eggstein M
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1219-23. PubMed ID: 3033010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1995 Apr; 122(8):561-8. PubMed ID: 7887548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensified conventional insulin treatment and neuropsychological impairment.
    Reichard P; Britz A; Rosenqvist U
    BMJ; 1991 Dec; 303(6815):1439-42. PubMed ID: 1773148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality control of intensified insulin therapy: HbA1 versus blood glucose.
    Bischof F; Meyerhoff C; Pfeiffer EF
    Horm Metab Res; 1994 Dec; 26(12):574-8. PubMed ID: 7705761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of CSII treatment on the function of the peripheral and visceral nerves in type I diabetics.
    Reichel G; Felsing U; Felsing W; Rabending G
    Exp Clin Endocrinol; 1985 Feb; 85(1):113-9. PubMed ID: 3987830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of plasma glucose control by continuous subcutaneous insulin infusion on nerve conduction.
    Bell PM; Sawhney B; Hayes JR; Hadden DR
    Ir J Med Sci; 1985 Oct; 154(10):378-84. PubMed ID: 4077452
    [No Abstract]   [Full Text] [Related]  

  • 40. Skin temperature changes during CSII in patients with diabetic neuropathy.
    van Ballegooie E; van Weerden TW
    Diabetes Care; 1984; 7(6):612-3. PubMed ID: 6510188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.